Journal of Orthopedic Oncology
Open Access

Skeletal metastases; Psychosocial impact; Patient needs; Psychological support; Social support; Palliative care; Survivorship planning

Introduction

Skeletal metastases, the spread of cancer to bones from primary tumors elsewhere in the body, represent a significant challenge in oncology. Beyond the physical burden they impose, skeletal metastases profoundly affect patients’ psychosocial well-being. The psychological and social impact of these metastases can be as debilitating as the physical symptoms themselves, often requiring comprehensive support beyond conventional medical treatment. This article delves into the psychosocial aspects of skeletal metastases and emphasizes the importance of addressing patients’ holistic needs [1].

Skeletal metastases present a complex challenge in oncology, not only due to their physical effects but also because of their profound psychosocial implications for patients. Beyond the pain and functional limitations they cause, skeletal metastases often trigger emotional distress and social disruptions, impacting patients’ overall wellbeing. Addressing these psychosocial needs requires a comprehensive approach that extends beyond conventional medical treatment. In this article, we explore the psychosocial impact of skeletal metastases and emphasize the importance of addressing patients’ holistic needs through psychological support, social interventions, palliative care, and survivorship planning [2].

Understanding the psychosocial impact

A diagnosis of skeletal metastases can trigger a range of emotional responses in patients, including fear, anxiety, depression, and a sense of loss of control. Patients may experience distress not only due to the physical pain and functional limitations caused by bone metastases but also due to existential concerns, such as mortality and changes in body image. Additionally, the uncertainty surrounding prognosis and treatment outcomes can further exacerbate psychological distress, leading to feelings of helplessness and hopelessness [3].

Socially, skeletal metastases can disrupt patients’ daily lives, affecting their ability to work, engage in social activities, and maintain relationships. The need for frequent medical appointments, hospitalizations, and treatments can impose significant logistical and financial burdens on patients and their families, further straining their social support networks [4].

Addressing psychosocial needs

Recognizing and addressing the psychosocial needs of patients with skeletal metastases is essential for comprehensive cancer care. Healthcare providers must adopt a holistic approach that goes beyond medical treatment to encompass psychological, social, and spiritual support.

Psychological support

Psychological interventions, such as counseling, psychotherapy, and support groups, play a crucial role in helping patients cope with the emotional impact of skeletal metastases. Cognitive-behavioral techniques can assist patients in managing anxiety and depression, while existential therapy can help them find meaning and purpose amidst their illness.

Social support

Encouraging patients to engage with support networks, including family, friends, and peer support groups, can alleviate feelings of isolation and provide practical assistance with daily tasks. Social workers can offer guidance on navigating financial challenges, accessing community resources, and communicating effectively with employers and healthcare providers [5].

Palliative care

Incorporating palliative care early in the treatment trajectory is essential for addressing patients’ physical and psychosocial needs. Palliative care teams specialize in symptom management, pain control, and optimizing quality of life, offering comprehensive support tailored to individual patient preferences and values.

Survivorship planning

Empowering patients to actively participate in survivorship planning can foster a sense of control and agency in their cancer journey. This involves discussing long-term goals, advance care planning, and supportive care options beyond active treatment, ensuring continuity of care and support throughout the cancer trajectory [6].

Discussion

The psychosocial impact of skeletal metastases extends far beyond the physical symptoms experienced by patients, profoundly affecting their emotional well-being and social functioning. In this discussion, we delve into the various aspects of the psychosocial impact of skeletal metastases and highlight the importance of addressing patients’ holistic needs beyond conventional treatment.

Patients diagnosed with skeletal metastases often experience a range of negative emotions, including fear, anxiety, depression, and existential concerns. The uncertainty surrounding prognosis and treatment outcomes can exacerbate these emotional distresses, leading to feelings of helplessness and hopelessness. Psychological support, such as counseling and psychotherapy, plays a crucial role in helping patients cope with these emotional challenges, providing them with strategies to manage anxiety and depression while fostering a sense of hope and resilience [7].

Skeletal metastases can disrupt patients’ social lives, affecting their ability to engage in daily activities, maintain relationships, and participate in social events. The need for frequent medical appointments, hospitalizations, and treatments can impose logistical challenges on patients and their families, leading to social isolation and financial strain. Social support interventions, including peer support groups and assistance from social workers, can mitigate these social disruptions by providing patients with practical assistance, emotional support, and access to community resources.

The psychosocial impact of skeletal metastases significantly influences patients’ overall quality of life. Beyond managing physical symptoms, optimizing patients’ psychosocial well-being is essential for enhancing their quality of life throughout the cancer trajectory. Palliative care, with its focus on symptom management, pain control, and holistic support, plays a critical role in improving patients’ quality of life by addressing their physical, emotional, and social needs. Additionally, survivorship planning empowers patients to actively engage in decision-making regarding their care, fostering a sense of control and autonomy in their cancer journey [8].

Addressing the psychosocial needs of patients with skeletal metastases requires a multidisciplinary approach that encompasses psychological, social, and spiritual support. By integrating these aspects of care into the treatment paradigm, healthcare providers can offer patients comprehensive support that goes beyond traditional medical interventions. This holistic approach not only improves patient outcomes but also enhances their overall well-being, empowering them to navigate the challenges of skeletal metastases with resilience and dignity [9].

Conclusion

Skeletal metastases impose a significant psychosocial burden on patients, affecting their emotional well-being, social functioning, and overall quality of life. Addressing patients’ holistic needs beyond medical treatment is essential for comprehensive cancer care. By integrating psychological, social, and spiritual support into the treatment paradigm, healthcare providers can improve patient outcomes and enhance overall well-being in the face of skeletal metastases.

Conflict of Interest

None

Acknowledgement

None

1. Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, et al. (2009) Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 219: 294-305.

Indexed at, Google Scholar, Crossref

2. Lye KL, Nordin N, Vidyadaran S, Thilakavathy K (2016) Mesenchymal stem cells: from stem cells to sarcomas. Cell Biol Int 40: 610-618.

Indexed at, Google Scholar, Crossref

3. Xiao W, Mohseny AB, Hogendoorn PC, Cleton-Jansen AM (2013) Mesenchymal stem cell transformation and sarcoma genesis. Clin Sarcoma Res 3: 10.

Indexed at, Google Scholar, Crossref

4. Cortini M, Avnet S, Baldini N (2017) Mesenchymal stroma: role in osteosarcoma progression. Cancer Lett 40:90-99.

Indexed at, Google Scholar, Crossref

5. Lemma S, Sboarina M, Porporato PE, Zini N, Sonveaux P, et al. (2016) Energy metabolism in osteoclast formation and activity. Int J Biochem Cell Biol 79: 168-180.

Indexed at, Google Scholar, Crossref

6. Lemma S, Di Pompo G, Porporato PE, Sboarina M, Russell S, et al. (2017) MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases. Biochim Biophys Acta Mol Basis Dis 1863: 3254-3264.

Indexed at, Google Scholar, Crossref

7. Sousa S, Clezardin P (2018) Bone-targeted therapies in cancer-induced bone disease. Calcif Tissue Int 102: 227-250.

Indexed at, Google Scholar, Crossref

8. Costa-Rodrigues J, Fernandes A, Fernandes MH (2011) Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors. J Cell Biochem 112: 3704-3713.

Indexed at, Google Scholar, Crossref

9. Salerno M, Avnet S, Alberghini M, Giunti A, Baldini N (2008) Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res 466: 2081-2091.

Indexed at, Google Scholar, Crossref

10. Alfranca A, Martinez-Cruzado L, Tornin J, Abarrategi A, Amaral T, et al. (2015) Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci 72: 3097-3113.

Indexed at, Google Scholar, Crossref